|
P001
|
|
|
P002
|
|
|
P003
|
Bimekizumab 3-year efficacy and safety in patients with hidradenitis suppurativa: Results from BE HEARD I&II and EXTENSION
Poster
1.1 Inflammatory and immune-mediated dermatoses
J. Ingram Department of Dermatology & Academic Wound Healing, Division of Infection and Immunity, Cardiff University, Cardiff, UK, and European Hidradenitis Suppurativa Foundation (EHSF) e.V., Dessau, Germany A. Kimball Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USAA. Garg Northwell, New Hyde Park, New York, USAF. Bechara Department of Dermatology, Venerology, and Allergology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany, and ICH – International Center for Hidradenitis Suppurativa/Acne Inversa, Ruhr-University Bochum, Bochum, GermanyB. Kirby European Hidradenitis Suppurativa Foundation (EHSF) e.V., Dessau, Germany, and St Vincent’s University Hospital, Elm Park and the Charles Institute, University College Dublin, Dublin, Republic of IrelandA. Morita Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, JapanW. Gulliver† European Hidradenitis Suppurativa Foundation (EHSF) e.V., Dessau, Germany, and Newlab Clinical Research Inc., St John's, Newfoundland and Labrador, CanadaB. Lukowski Vedim/UCB, Warsaw, PolandN. Hurni
Presenter
UCB, Bulle, SwitzerlandC. Sayed European Hidradenitis Suppurativa Foundation (EHSF) e.V., Dessau, Germany, and Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
|
|
P004
|
|
|
P005
|
|
|
P006
|
Severe confluent and reticulated papillomatosis
Poster
1.1 Inflammatory and immune-mediated dermatoses
B. Signer
Presenter
Inselspital BernS. Seyed Jafari Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandS. Böll Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
|
|
P007
|
|
|
P008
|
|
|
P009
|
|
|
P010
|
|
|
P011
|
|
|
P012
|
|
|
P013
|
|
|
P014
|
|
|
P015
|
|
|
P016
|
|
|
P017
|
|
|
P018
|
|
|
P019
|
|
|
P020
|
|
|
P021
|
Lebrikizumab Provides Clinically Meaningful Response in Face and Hands in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: ADhope 1 Study
Poster
1.1 Inflammatory and immune-mediated dermatoses
C. Vestergaard Department of Dermatology and Venerology, Aarhus University Hospital, Aarhus, DenmarkJ. Seneschal Department of Dermatology, University of Bordeaux, Bordeaux, France; Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, Bordeaux, FranceS. Weidinger Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, GermanyA. Wollenberg University Medical Center of Augsburg, Augsburg, Germany; Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany; Department of Dermatology and Allergology, LMU Hospital, Munich, GermanyA. Irvine Department of Clinical Medicine, Trinity College Dublin, Dublin, IrelandH. Agell Almirall S.A., Barcelona, SpainJ. Bancells Almirall S.A., Barcelona, SpainV. Sapena Almirall S.A., Barcelona, SpainF. Oestereich
Presenter
Almirall AG, Wallisellen, SwitzerlandD. Thaçi Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany
|
|
P022
|
|
|
P023
|
|
|
P024
|
Efficacy and Safety of Lebrikizumab is Maintained up to 4 Years in Patients with Moderate-to-Severe Atopic Dermatitis: First Year of ADlong Long-Term Extension Trial
Poster
1.1 Inflammatory and immune-mediated dermatoses
S. Weidinger Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, GermanyA. Irvine Department of Clinical Medicine, Trinity College Dublin, Dublin, IrelandD. Thaçi Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, GermanyJ. Szepietowski Division of Dermatology, Venereology and Clinical Immunology, Faculty of Medicine, Wrocław University of Science and Technology, Wrocław, PolandT. Biedermann Department of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, GermanyH. Agell Almirall S.A.Y. Mihaylov Almirall S.A., Barcelona, SpainB. Kostov Almirall S.A., Barcelona, SpainR. Coll Almirall S.A., Barcelona, SpainW. Romero Eli Lilly and Company, Indianapolis, IN, USAF. Oestereich
Presenter
Almirall AGK. Reich Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
|
|
P025
|
Bimekizumab Reduces Draining Tunnel Count Over 3 Years in Hidradenitis Suppurativa: Data from BE HEARD EXTENSION
Poster
1.1 Inflammatory and immune-mediated dermatoses
J. Hsiao Department of Dermatology, University of Southern California, Los Angeles, CA, USAH. Naik Department of Dermatology, University of California, San Francisco, CA, USAA. Kimball Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USAA. Martorell Department of Dermatology, Hospital de Manises, Valencia, Spain, and European Hidradenitis Suppurativa Foundation e.V., Dessau, GermanyP. Becherel European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany, Unité de Dermatologie et Immunologie Clinique, Hôpital Privé d'Antony Université, Paris, France, and Groupe d'Etudes Multicentriques Reso, Saint-Maur-des-Fossés, FranceM. Gooderham SKiN Centre for Dermatology, Probity Medical Research, Peterborough, ON, Canada, and Queen’s University, Kingston, ON, CanadaT. Maekawa Department of Dermatology, Jichi Medical University, Saitama Medical Center, Saitama, JapanB. Lukowski Vedim/UCB, Warsaw, PolandN. Hurni
Presenter
UCB, Bulle, SwitzerlandF. Bechara Department of Dermatology, Venerology, and Allergology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany, and ICH – International Center for Hidradenitis Suppurativa / Acne Inversa, Ruhr-University Bochum, Germany
|
|
P026
|
Bimekizumab Long-Term On-Treatment Remission and Associated Sustained Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis Across Five Phase 3/3b Trials
Poster
1.1 Inflammatory and immune-mediated dermatoses
J. Merola Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center, Dallas, TX, USAA. Armstrong University of California Los Angeles (UCLA), Los Angeles, CA, USAD. Balak Department of Dermatology, Leiden University Medical Center, Leiden, The NetherlandsJ. Hawkes Oregon Medical Research Center, Portland, OR, USAL. Kircik Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USAF. Lovegrove Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON, CanadaT. Jeffray UCB, Oakville, ON, CanadaS. Kavanagh UCB, Morrisville, NC, USAN. Hurni
Presenter
UCB, Bulle, SwitzerlandR. Langley Division of Clinical Dermatology & Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, NS, Canada
|
|
P027
|
|
|
P028
|
|
|
P029
|
Once-daily Oral Zasocitinib Demonstrates Rapid and Reproducible Skin Clearance with a Consistent Safety Profile in Moderate-to-Severe Plaque Psoriasis: Results from Two Randomized Phase 3 Trials (LATITUDE-PsO-3001 and 3002)
Poster
1.1 Inflammatory and immune-mediated dermatoses
M. Gooderham SKiNCentre for Dermatology, Queen’s University and Probity Medical Research, Peterborough, Ontario, CanadaV. Laquer First OC Dermatology Research, Fountain Valley, CA, USAJ. Zhang Department of Dermatology, Peking University People's Hospital, Beijing, ChinaJ. Narbutt Department of Dermatology, Paediatric Dermatology and Oncology, Medical University of Lodz, Lodz, PolandA. Morita Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, JapanP. Luna Hospital Alemán de Buenos Aires, Buenos Aires, ArgentinaW. Zhang Takeda Development Center Americas, Inc., Cambridge, MA, USAW. Winkelman Takeda Development Center Americas, Inc., Cambridge, MA, USAE. Angellotti Takeda Development Center Americas, Inc., Cambridge, MA, USAM. Brunori
Presenter
|
|
P030
|
|
|
P031
|
|
|
P032
|
|
|
P033
|
|
|
P034
|
|
|
P035
|
|
|
P036
|
Urticarial annular eruption revealing Capnocytophaga canimorsus bacteraemia after a dog bite
Poster
1.1 Inflammatory and immune-mediated dermatoses
A. Pagani
Presenter
HUG - Hôpitaux Universitaires de GenèveM. Sabau HUG - Hôpitaux Universitaires de GenèveR. Merat HUG - Hôpitaux Universitaires de GenèveS. Menzinger HUG - Hôpitaux Universitaires de GenèveG. Kaya HUG - Hôpitaux Universitaires de GenèveD. Pastor HUG - Hôpitaux Universitaires de GenèveG. Russo HUG - Hôpitaux Universitaires de Genève
|
|
P037
|
|
|
P038
|
|
|
P039
|
|
|
P040
|
|
|
P041
|
A Human 3D Epidermal Model of Acute Cutaneous GVHD
Poster
1.1 Inflammatory and immune-mediated dermatoses
J. Fröhlich
Presenter
Department of Biomedicine, University Hospital and University of BaselT. Dittmar Department of Biomedicine, University Hospital and University of BaselE. Parente Department of Biomedicine, University Hospital and University of BaselA. Chancellor Department of Biomedicine, University Hospital and University of BaselE. Contassot Department of Biomedicine, University Hospital and University of BaselA. Navarini Department of Biomedicine, University Hospital and University of Basel
|
|
P042
|
|
|
P043
|
|
|
P044
|
|
|
P045
|
|
|
P046
|
|
|
P047
|
|
|
P048
|
|
|
P049
|
|
|
P050
|
|
|
P051
|
|
|
P052
|
Autochthonous leishmaniasis in Europe
Poster
1.2 Infectious Diseases (including STD-STI)
B. Signer
Presenter
Inselspital BernL. Borradori Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandR. Wolf Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandA. Junge Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
|
|
P053
|
|
|
P054
|
|
|
P055
|
New insights into neurosyphilis by digitizing manuscript medical records
Poster
1.2 Infectious Diseases (including STD-STI)
M. Lamrayah
Presenter
Faculty of Medicine, University of Geneva, SwitzerlandS. Gabay Faculty of Letters, University of Geneva, SwitzerlandJ. Falciola Hopitaux Universitaire de Genève HUG/UniGeL. Toutous Trellu Hopitaux Universitaire de Genève HUG/UniGe
|
|
P056
|
|
|
P057
|
|
|
P058
|
Virtual Reality in Psychodermatology: A Novel Dimension of Treatment
Poster
2.1 Psychodermatology
R. Velikova
Presenter
University Hospital Basel, Department of Dermatology, Basel, SwitzerlandC. Abel-Green University Hospital Basel, Department of Dermatology, Basel, SwitzerlandS. Müller University Hospital Basel, Department of Dermatology, Basel, Switzerland
|
|
P059
|
High Awareness but Limited Assessment of Psychological and Sexual Health in Dermatology Practice: A Survey of Swiss Dermatologists
Poster
2.1 Psychodermatology
K. Kedra
Presenter
University of RzeszowS. Cazzaniga Bern University Hospital, Bern, SwitzerlandH. Beltraminelli Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.N. Yawalkar Bern University Hospital, Bern, SwitzerlandK. Heidemeyer Bern University Hospital, Bern, SwitzerlandA. Reich University of RzeszowA. Rabufetti Bern University Hospital, Bern, Switzerland
|
|
P060
|
|
|
P061
|
|
|
P062
|
|
|
P063
|
|
|
P064
|
|
|
P065
|
|
|
P066
|
|
|
P067
|
|
|
P068
|
|
|
P069
|
|
|
P070
|
|
|
P071
|
Avapritinib Achieves Durable Improvement in Skin Findings With a Well-Tolerated Safety Profile in Patients With Indolent Systemic Mastocytosis: Long-term Analyses From the PIONEER Study
Poster
2.2 Dermato-Oncology
K. Hartmann
Presenter
University Hospital Basel and University of BaselC. Akin Division of Allergy and Clinical Immunology, Department of Internal Medicine, University of MichiganF. Siebenhaar Institute of Allergology, Charité-Universitat Berlin and Humboldt-Universitat zu BerlinS. Broesby-Olsen Department of Dermatology and Allergy Centre, Odense University HospitalH. Oude Elberink Department of Allergology, Groningen Research Institute Asthma and COPD, University Medical Center, University of GroningenT. George Huntsman Cancer Institute and ARUP Laboratories, Department of Pathology, University of Utah School of MedicineH. Lin Blueprint Medicines CorporationI. Bidollari Blueprint Medicines CorporationA. Doyle Blueprint Medicines CorporationL. Madigan Department of Dermatology, University of Utah
|
|
P072
|
|
|
P073
|
|
|
P074
|
Interpreting Baseline Serum Tryptase During Screening for Clonal Mast Cell Disease in the Presence or Absence of Hereditary Alpha-Tryptasemia
Poster
2.2 Dermato-Oncology
V. Sabato University of Antwerp and Antwerp University HospitalM. Giannetti Division of Allergy and Clinical Immunology, Brigham and Women’s HospitalC. Akin Division of Allergy and Clinical Immunology, Department of Internal Medicine, University of MichiganJ. Jurcic Herbert Irving Cancer Center, and New York-Presbyterian HospitalM. Jara-Acevedo Spanish Network on Mastocytosis and Biomedical Research Institute of Salamanca, University of Salamanca and Centro de Investigación Biomédica en Red Cáncer (CIBERONC; CB16/12/00400)B. Poladura Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast), Virgen del Valle HospitalR. Sandoval-Arroyo Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast), Virgen del Valle HospitalA. Orfao Spanish Network on Mastocytosis (REMA) and Centro de Investigación Biomédica en Red Cáncer (CIBERONC; CB16/12/00400) and Biomedical Research Institute of Salamanca, University of SalamancaK. Hartmann
Presenter
Division of Allergy, Department of Dermatology; Department of Clinical Research; and Department of Biomedicine, University Hospital Basel, and University of BaselI. Álvarez-Twose Spanish Network on Mastocytosis (REMA) and Centro de Investigación Biomédica en Red Cáncer (CIBERONC; CB16/12/00400) and Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast), Virgen del Valle Hospital
|
|
P075
|
|
|
P076
|
|
|
P077
|
Ten years retrospective analysis of clinical characteristics Vitiligo-like depigmentation in treated melanoma patients
Poster
2.2 Dermato-Oncology
G. Caro
Presenter
Department of Dermatology, Ente Ospedaliero Cantonale (EOC), Bellinzona, SwitzerlandM. Rogan Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, SwitzerlandA. Nepote Department of Dermatology, Ente Ospedaliero Cantonale (EOC), Bellinzona, SwitzerlandM. Hilbers Department of Dermatology, Ente Ospedaliero Cantonale (EOC), Bellinzona, SwitzerlandG. Burghgraeve Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, SwitzerlandC. Mangas Department of Dermatology, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland
|
|
P078
|
|
|
P079
|
|
|
P081
|
|
|
P082
|
|
|
P083
|
|
|
P084
|
|
|
P086
|
|
|
P087
|
|
|
P088
|
|
|
P089
|
|
|
P090
|
Purple Rain Under Wood’s Light: Illuminating Diagnostic Clues in Dermatology
Poster
2.4 Therapy, diagnostic tools, and devices
R. Curatolo
Presenter
EOC (Ente Ospedaliero Cantonale) - Ospedale Regionale di Bellinzona e ValliH. Beltraminelli EOC (Ente Ospedaliero Cantonale) - Ospedale Regionale di Bellinzona e ValliM. Madanchi EOC (Ente Ospedaliero Cantonale) - Ospedale Regionale di Bellinzona e Valli
|
|
P091
|
|
|
P092
|
Grid patch treatment for localized pruritus: A case series
Poster
2.4 Therapy, diagnostic tools, and devices
C. Andrist University Hospital BaselH. Aviv
Presenter
University Hospital BaselA. Derleth University Hospital BaselL. Markovic University Hospital BaselA. Navarini University Hospital BaselS. Müller University Hospital Basel
|
|
P093
|
|
|
P094
|
Lebrikizumab for Paediatric Patients Aged ≥6 Months with Moderate-to-Severe AD: Phase 3 ADorable-1 Week-16 Results
Poster
3.1 Dermato-Paediatrics
L. Eichenfield Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, United StatesJ. Ornelas Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, United StatesV. Prajapati Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, CanadaC. Yang Chang Gung University College of Medicine, Taoyuan, TaiwanA. Tanaka Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanS. Weidinger Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Ratzeburger Allee 160, 23538 Lübeck, GermanyC. Flohr Department of Dermatology and Population Health Sciences, King’s College London, London, United KingdomE. Swanson Ada West Dermatology, St Luke's Children's Hospital, ID 83642, Idaho, United StatesL. Martin School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney AustraliaF. Oestereich
Presenter
Almirall AGA. Paller Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States
|
|
P095
|
|
|
P096
|
Spontaneous resolution of congenital melanocytic naevi on the scalp
Poster
3.1 Dermato-Paediatrics
N. Knöpfel
Presenter
University Children's Hospital Zurich; Kantonsspital AarauI. Luchsinger University Children's Hospital ZurichJ. Lanz University Children's Hospital Zurich; HOCH Kantonsspital St. GallenA. Schwieger-Briel University Children's Hospital ZurichM. Theiler Pang University Children's Hospital ZurichL. Weibel University Children's Hospital Zurich
|
|
P097
|
New-onset localized hyperhidrosis reveals a dynamic phenotype in involuting infantile hemangiomas
Poster
3.1 Dermato-Paediatrics
J. Lanz University Children's Hospital Zurich; HOCH Kantonnspital St GallenL. Weibel University Children`s Hospital ZurichM. Theiler Pang University Children's Hospital ZurichA. Schwieger-Briel University Children's Hospital ZurichI. Luchsinger University Children's Hospital ZurichH. Khov University Hospital Zurich (USZ)I. Colmenero University Children's Hospital Niño Jesus, MadridA. Cozzio HOCH - Kantonsspital St.GallenN. Knöpfel
Presenter
University Children's Hospital Zurich; Kantonsspital Aarau
|
|
P098
|
Pediatric extragenital lichen sclerosus: a diagnostic clue to occult genital disease
Poster
3.1 Dermato-Paediatrics
L. Bruschi
Presenter
EOC (Ente Ospadaliero Cantonale) - Ospedale Regionale di LuganoB. Cattrini EOC (Ente Ospedaliero Cantonale) - Ospedale Regionale di Bellinzona e ValliS. Leoni Parvex Cantonal Institute of Pathology, Ente Ospedaliero Cantonale, Locarno, SwitzerlandI. Terrani EOC (Ente Ospadaliero Cantonale) - Ospedale Regionale di Lugano
|
|
P099
|
|
|
P100
|
|
|
P101
|
|
|
P102
|
|
|
P103
|
Real-World Characteristics of Atopic Dermatitis Patients Treated with Nemolizumab: Data from the TREATswitzerland Registry*
Poster
3.2 Dermato-Allergology
E. Janušonytė
Presenter
Division of Dermatology, Geneva University HospitalsT. Caplanusi Department of Dermatology and Venereology, University Hospital of Lausanne, Lausanne, SwitzerlandK. Hartmann Division of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, Basel, SwitzerlandW. Boehncke Division of Dermatology, Geneva University HospitalsS. Radonjic-Hoesli Department of Dermatology, Inselspital, Bern University Hospital, University of BernK. Thormann Department of Dermatology, Inselspital, Bern University Hospital, University of BernD. Simon Department of Dermatology, Inselspital, Bern University Hospital, University of Berns. TREATswitzerland
|
|
P104
|
|
|
P105
|
|
|
P106
|
|
|
P107
|
|
|
P108
|
|
|
P109
|
|
|
P110
|
|
|
P111
|
|
|
P112
|
New insights in eczema of the elderly: clinical characterization and skin mRNA profiling
Poster
3.2 Dermato-Allergology
K. Kotsia Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandE. Contassot Department of Biomedcine, University Hospital Basel and University of Basel, Basel, SwitzerlandS. Cazzaniga Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandK. Hartmann Department of Clinical Research, University Hospital Basel and University of Basel, Basel, SwitzerlandD. Simon Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandS. Radonjic-Hoesli
Presenter
Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
|
|
P113
|
The chromatin guardian ATRX is a strong prognostic biomarker in melanoma
Poster
3.3 Dermato-Pathology
C. Frei
Presenter
University Hospital of ZurichC. Litchfield University Hospital of ZurichA. Mihic Bavarian State Office for Health and Food SafetyF. Prutek University Hospital of ZurichA. Fitsche University Hospital of ZurichF. Wiesmann University Hospital of ZurichM. Wanner Cancer Registry Zurich, Zug, Schaffhausen and SchwyzB. Sobottka University Hospital of ZurichD. Mihic-Probst University Hospital of Zurich
|
|
P114
|
|
|
P115
|
Beyond histiocytosis: xanthogranulomatous skin lesions revealing three distinct clonal diseases
Poster
3.3 Dermato-Pathology
N. Staub
Presenter
Inselspital - Universitätsspital BernT. Hempel Inselspital - Universitätsspital BernM. Gottschalk Inselspital - Universitätsspital BernL. Vuille-Gueissaz Inselspital - Universitätsspital BernR. Wolf Inselspital - Universitätsspital BernL. Borradori Inselspital - Universitätsspital BernC. Schlapbach Inselspital - Universitätsspital BernF. Dimitriou Inselspital - Universitätsspital Bern
|
|
P116
|
|
|
P117
|
A novel, sustainable and cost-effective 3D immunocompetent in-vitro wound model for animal-free wound healing research
Poster
3.4 Basic and Translational Research
Q. Suppiyar
Presenter
University Hospital Duesseldorf , Department of Vascular and Endovascular Surgery W. Ibing University Hospital Duesseldorf , Department of Vascular and Endovascular Surgery W. Garabet University Hospital Duesseldorf , Department of Vascular and Endovascular Surgery M. Wagenhäuser University Hospital Duesseldorf , Department of Vascular and Endovascular Surgery H. Schelzig University Hospital Duesseldorf , Department of Vascular and Endovascular Surgery J. Rembe University Hospital Duesseldorf , Department of Vascular and Endovascular Surgery
|
|
P118
|
|
|
P119
|
Misnomers in dermatology and other medical specialties - How to deal with science fiction?
Poster
3.4 Basic and Translational Research
R. Velikova
Presenter
University Hospital Basel, Department of Dermatology, Basel, SwitzerlandV. Griss University Hospital Basel, Department of Dermatology, Basel, SwitzerlandP. Itin University Hospital Basel, Department of Dermatology, Basel, SwitzerlandD. Vogt Department of Clinical Research, University Hospital Basel, University of BaselS. Müller University Hospital Basel, Department of Dermatology, Basel, Switzerland
|
|
P120
|
|
|
P121
|
Cancer-germline antigens as potential candidates for immunotherapy in squamous cell carcinoma of the oral cavity
Poster
3.4 Basic and Translational Research
X. Berschin
Presenter
Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Kilic Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Abdou Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandD. Amozova Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandO. Pop Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Schmid Department of Pathology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Purde Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandC. Bicer Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandS. Meili Institute of Immunobiology & Department of Otorhinolaryngology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandL. Flatz Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, Switzerland & Department of Dermatology, University Hospital Tübingen, Tübingen, Germany
|
|
P122
|
Autoreactive T-cells Targeting Melanocyte Self-Antigens in Immune Checkpoint Inhibitor-induced Vitiligo
Poster
3.4 Basic and Translational Research
C. Bicer
Presenter
Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandH. Glaser Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandD. Amozova Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Abdou Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandX. Berschin Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandR. Mendez Lopez Department of Dermatology, HOCH Kantonssiptal St. Gallen, St. Gallen, SwitzerlandM. Jörger Department of Oncology and Hematology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandA. Cozzio Department of Dermatology, HOCH Kantonssiptal St. Gallen, St. Gallen, SwitzerlandO. Pop Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandL. Flatz Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, Switzerland & Department of Dermatology, University Hospital Tübingen, Tübingen, Germany
|
|
P123
|
Cancer-Germline Antigen-Specific CD8⁺ T-cell Responses in Stage IV Melanoma Patients under Immune Checkpoint Blockade
Poster
3.4 Basic and Translational Research
D. Amozova
Presenter
Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Abdou Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandF. Berner Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandO. Hasan Ali Department of Dermatology, University Hospital Zurich, Zurich, SwitzerlandS. Ring Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandO. Pop Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandA. Cozzio Department of Dermatology and Allergology, HOCH Kantonsspital St.Gallen, St.Gallen, SchwitzerlandL. Flatz Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, Switzerland & Department of Dermatology, University Hospital Tübingen, Tübingen, Germany
|
|
P124
|
Autocrine activation of EGFR-HER3-dependent pathways in melanoma
Poster
3.4 Basic and Translational Research
X. Berschin
Presenter
Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, SwitzerlandA. Nurmammadova Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland & MD Anderson Cancer Center, UTH Huston, Houston, USAB. Broske Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland & Institute of Experimental Oncology, University Hospital Bonn, Bonn, GermanyH. Niessner Department of Dermatology, University Hospital Tübingen, Tübingen, GermanyO. Pop Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, SwitzerlandL. Flatz Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland & Department of Dermatology, University Hospital Tübingen, Tübingen, Germany
|
|
P125
|
Late relapse in thin melanoma: a pilot study
Poster
3.4 Basic and Translational Research
D. Amozova
Presenter
Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandO. Pop Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Mendez Lopez Department of Oncology and Hematology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Abdou Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandL. Flatz Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland & Department of Dermatology, University Hospital Tübingen, Tübingen, GermanyR. Mendez Lopez Department of Dermatology and Allergology, HOCH Kantonsspital St.Gallen, St.Gallen, Schwitzerland
|
|
P126
|
Endogenous antitumor immunity is established early and persists throughout melanoma progression
Poster
3.4 Basic and Translational Research
D. Amozova
Presenter
Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandO. Pop Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandS. Ring Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandV. Walter Department of Dermatology, University Hospital Tübingen, Tübingen, GermanyM. Abdou Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandA. Jochum Institute of Pathology, HOCH Kantonsspital St.Gallen, St.Gallen, Switzerland A. Cozzio Department of Dermatology and Allergology, HOCH Kantonsspital St.Gallen, St.Gallen, SchwitzerlandR. Dummer Department of Dermatology, University Hospital Zurich, Zurich, SwitzerlandM. Levesque Department of Dermatology, University Hospital Zurich, Zurich, SwitzerlandL. Flatz Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, Switzerland & Department of Dermatology, University Hospital Tübingen, Tübingen, Germany
|
|
P127
|
|
|
P128
|
|
|
P129
|
Birth-Hogg-Dubé-Syndrom: A small dermatologic detail responsible for a whole diagnosis
Poster
3.5 Genodermatoses
A. Schumacher
Presenter
Dermatology & Skin Care Clinic, SwitzerlandF. Ney Dermatology & Skin Care Clinic, SwitzerlandV. Emelianov Dermatology & Skin Care Clinic, SwitzerlandA. Valipour Dermatology & Skin Care Clinic, SwitzerlandA. Jalili Dermatology & Skin Care Clinic, SwitzerlandR. Genders Dermatology & Skin Care Clinic, Switzerland
|
|
P130
|
When itch goes genetic: A gain-of-function JAK1 variant is associated with increased JAK/STAT and IL-31 signalling
Poster
3.5 Genodermatoses
N. Bertschi Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandS. Schärli Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandS. Wildi Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandR. Wolf Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandJ. Kick Department of Human Genetics, Inselspital, Bern Hospital, University of Bern, Bern, Switzerland L. Gogoll Department of Human Genetics, Inselspital, Bern Hospital, University of Bern, Bern, Switzerland J. Sanz Department of Human Genetics, Inselspital, Bern Hospital, University of Bern, Bern, Switzerland L. Weibel Pediatric Skin Center, Department of Dermatology, University Children's Hospital Zurich, Zurich, SwitzerlandC. Schlapbach Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandA. Reimer-Taschenbrecker
Presenter
Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
|
|
P131
|
|
|
P132
|
Fast progressive primary hypertrophic osteoarthropathy type 2 improved following etoricoxib therapy
Poster
3.5 Genodermatoses
R. Curatolo
Presenter
Universitätsspital Basel - DermatologieM. Madanchi Universitätsspital Basel - DermatologieA. Navarini Universitätsspital Basel - DermatologieP. Itin Praxis DermatologieV. Rusu Department of Human Genetics, Inselspital, Bern Hospital, University of Bern, Bern, Switzerland P. Chatelain Department of Human Genetics, Inselspital, Bern Hospital, University of Bern, Bern, Switzerland J. Sanz Department of Human Genetics, Inselspital, Bern Hospital, University of Bern, Bern, Switzerland P. Seitz Department of Rheumatology and Immunology, InselspitalL. Borradori Department of Dermatology Inselspital BernA. Reimer-Taschenbrecker Department of Dermatology Inselspital Bern
|
|
P133
|
|
|
P134
|
|
|
P135
|
|
|
P136
|
|
|
P137
|
|
|
P138
|
|
|
P139
|
Unexpected Admissions After Planned Outpatient Non-Melanoma Skin Cancer Reconstruction: Risk Factors and a Bedside Risk Score
Poster
3.6 Surgery
T. Schaschinger
Presenter
Medical Faculty, University of Heidelberg, Heidelberg, Germany F. Marcela Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, GermanyT. Niederegger Medical Faculty, University of Heidelberg, Heidelberg, Germany J. Brandt Medical Faculty, University of Heidelberg, Heidelberg, Germany D. Orgill Division of Plastic Surgery, Department of Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA A. C. Panayi Department of Cranio-Maxillofacial and Oral Surgery, University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich, 8091, SwitzerlandG. Hundeshagen Department of Hand-, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center. BG Trauma Center Ludwigshafen, University of Heidelberg, Ludwigshafen, Germany
|
|
P140
|
|
|
P141
|
|
|
P142
|
|
|
P143
|
|
|
P144
|
|
|
P145
|
Patient education in dermatology
Poster
3.7 Other topics – Not defined
R. Herren
Presenter
Inselspital BernM. Stöckli Bern University HospitalM. Giacomotti Bern University Hospital, InselspitalM. Marfurt Bern University Hospital
|
|
P146
|
|
|
P147
|
|
|
P148
|
|
|
P149
|
|
|
P150
|
|